HR-10068-119
Referred to the House Committee on Energy and Commerce.
Sponsored by Debbie Wasserman Schultz (D-FL)
What it does
This bill would direct the CDC to create a "Reducing Youth Use of E-Cigarettes Initiative" that researches youth vaping patterns, develops guidance for health providers and schools, funds state and tribal health departments through existing tobacco control programs, and runs a public education campaign. It authorizes $100 million per year in federal funding for fiscal years 2027 through 2031.
Who benefits
Youth and young adults who use or are at risk of using e-cigarettes, public health researchers studying vaping, state and tribal health departments and Freely Associated State health departments receiving CDC cooperative agreement funding, and cessation service providers such as quitlines. Schools and healthcare providers would benefit from new federally developed clinical guidance.
Who is hurt
E-cigarette manufacturers and retailers may face increased scrutiny and reputational pressure from research findings and public campaigns, though the bill imposes no direct sales restrictions or penalties on them. Taxpayers bear the $500 million total cost over five years. Other public health priorities competing for CDC discretionary funding could see relatively less attention.
Supporters argue
Supporters argue youth e-cigarette use remains a significant public health concern, with CDC survey data showing millions of middle and high school students report vaping, and that better surveillance, cessation resources, and public education are necessary tools to address nicotine addiction among minors. They contend this builds on existing CDC tobacco control infrastructure rather than creating new regulatory burdens, making it a low-cost, evidence-based response to an ongoing trend.
Opponents argue
Opponents argue the bill authorizes significant new federal spending ($500 million over five years) for research and messaging campaigns whose effectiveness in changing youth behavior is unproven, duplicating work already done by FDA and state programs. They contend that federal public health campaigns have had mixed historical success at reducing youth substance use and that funds might be better targeted toward direct enforcement against illegal sales to minors rather than research and messaging.
Constitutional context
Congress has broad authority under the Spending Clause to fund public health research and grants to states through agencies like the CDC, and this bill creates no mandate, tax, or restriction that would implicate Commerce Clause limits addressed in NFIB v. Sebelius. It raises no significant constitutional question beyond Congress's enumerated spending power.
Checks and balances
Congress authorizes funding and requires HHS to report a public implementation strategy to relevant committees within 90 days, giving Congress oversight; the executive branch (HHS/CDC) retains discretion over how research and campaign activities are carried out within that funding.
Historical precedent
This builds on the CDC's existing National Tobacco Control Program and prior federal anti-vaping public education efforts, such as the FDA's "The Real Cost" youth tobacco prevention campaign.